JP2002507613A5 - - Google Patents

Download PDF

Info

Publication number
JP2002507613A5
JP2002507613A5 JP2000537874A JP2000537874A JP2002507613A5 JP 2002507613 A5 JP2002507613 A5 JP 2002507613A5 JP 2000537874 A JP2000537874 A JP 2000537874A JP 2000537874 A JP2000537874 A JP 2000537874A JP 2002507613 A5 JP2002507613 A5 JP 2002507613A5
Authority
JP
Japan
Prior art keywords
piperid
fluorobenzyl
propenyl
melting point
benzoxazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000537874A
Other languages
English (en)
Japanese (ja)
Other versions
JP4451565B2 (ja
JP2002507613A (ja
Filing date
Publication date
Priority claimed from DE19812331A external-priority patent/DE19812331A1/de
Application filed filed Critical
Publication of JP2002507613A publication Critical patent/JP2002507613A/ja
Publication of JP2002507613A5 publication Critical patent/JP2002507613A5/ja
Application granted granted Critical
Publication of JP4451565B2 publication Critical patent/JP4451565B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000537874A 1998-03-20 1999-03-11 ピペリジン誘導体 Expired - Fee Related JP4451565B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19812331.0 1998-03-20
DE19812331A DE19812331A1 (de) 1998-03-20 1998-03-20 Piperidinderivate
PCT/EP1999/001573 WO1999048891A1 (de) 1998-03-20 1999-03-11 1-(3 -heteroarylpropyl- oder -prop -2-enyl) -4-benzylpiperidine als nmda-rezeptor-antagonisten

Publications (3)

Publication Number Publication Date
JP2002507613A JP2002507613A (ja) 2002-03-12
JP2002507613A5 true JP2002507613A5 (https=) 2010-01-21
JP4451565B2 JP4451565B2 (ja) 2010-04-14

Family

ID=7861717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000537874A Expired - Fee Related JP4451565B2 (ja) 1998-03-20 1999-03-11 ピペリジン誘導体

Country Status (22)

Country Link
US (1) US6548516B1 (https=)
EP (1) EP1068202B1 (https=)
JP (1) JP4451565B2 (https=)
KR (1) KR20010042047A (https=)
CN (1) CN1123571C (https=)
AR (1) AR014747A1 (https=)
AT (1) ATE416173T1 (https=)
AU (1) AU747900B2 (https=)
BR (1) BR9908902A (https=)
CA (1) CA2324339C (https=)
DE (2) DE19812331A1 (https=)
DK (1) DK1068202T3 (https=)
ES (1) ES2316184T3 (https=)
HU (1) HUP0101220A3 (https=)
ID (1) ID26125A (https=)
NO (1) NO20004668L (https=)
PL (1) PL342732A1 (https=)
PT (1) PT1068202E (https=)
RU (1) RU2217429C2 (https=)
SK (1) SK13692000A3 (https=)
WO (1) WO1999048891A1 (https=)
ZA (1) ZA992191B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2409006A1 (en) 2000-05-31 2001-12-06 Warner-Lambert Company Biciclic cyclohexylamines and their use as nmda receptor antogonists
JP2003535851A (ja) * 2000-06-06 2003-12-02 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 二環式シクロヘキシルアミン類およびそれらのnmda受容体アンタゴニストとしての使用
JP2004516295A (ja) 2000-12-21 2004-06-03 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー サブタイプ選択的なn−メチル−d−アスパラギン酸拮抗薬としてのピペリジン誘導体
MXPA02002749A (es) 2001-03-27 2002-10-28 Warner Lambert Co Derivados de ciclohexilamina como antagonistas del subtipo selectivo del n-metil-d-aspartato.
DE10248067A1 (de) * 2002-10-07 2004-04-15 Proteosys Ag Heteroarylpropyl-Piperazine und Heteroarylpropyl-Piperidine
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
CA2784119A1 (en) 2009-12-15 2011-06-23 Neurop, Inc. Compounds for the treatment of neurologic disorders
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
CN102133198B (zh) * 2011-03-09 2012-02-08 北京四环科宝制药有限公司 一种酒石酸艾芬地尔冻干粉针剂及其制备方法
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
CN103965188A (zh) * 2013-01-29 2014-08-06 中山大学 含硒多奈哌齐类似物
RS61688B1 (sr) 2015-04-29 2021-05-31 Janssen Pharmaceutica Nv Azabenzimidazoli i njihiova upotreba kao modulatori ampa receptora
US10604484B2 (en) * 2015-04-29 2020-03-31 Janssen Pharmaceutica Nv Indolone compounds and their use as AMPA receptor modulators
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
JP3084729B2 (ja) * 1990-06-15 2000-09-04 横河電機株式会社 デジタルオシロスコープ
TW281670B (https=) * 1993-09-02 1996-07-21 Hoffmann La Roche
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1996002250A1 (en) 1994-07-20 1996-02-01 Acea Pharmaceuticals Inc. Haloperidol analogs and the use thereof
ATE174915T1 (de) 1994-10-31 1999-01-15 Merck Patent Gmbh Benzylpiperidinderivate mit hoher affinität zu bindungsstellen von aminosäure-rezeptoren
ZA9610745B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
DE19643790A1 (de) 1996-10-30 1998-05-07 Merck Patent Gmbh Benzoxazol-Derivat

Similar Documents

Publication Publication Date Title
JP2002507613A5 (https=)
JP2004521087A5 (https=)
JP2009535362A5 (https=)
JP2006524225A5 (https=)
JP2005510473A5 (https=)
JP2007517010A5 (https=)
JPWO2024019103A5 (https=)
JP2010513304A5 (https=)
PT2305656E (pt) Isómeros óticos de um metabolito de iloperidona
PT1337529E (pt) Derivados heterociclilalquilpiperidina, sua preparação e composições que os contêm
RU2005134006A (ru) Производные 4-(4-{гетероциклилалкокси}фенил0-1-(гетероциклилкарбонил)пиперидина и родственные соединения как антагонисты гистамина н3 для лечения неврологических заболеваний, таких как болезнь альцгеймера
JPH0741475A (ja) 薬剤として有用な3−アリールカルボニル−1h−インドール
JP2003505458A5 (https=)
TW200800185A (en) Acid secretion inhibitor
HRP20110640T1 (hr) Derivati cikličkih amida i njihova proizvodnja te njihova uporaba kao antitromboznih sredstava
JP2010505809A5 (https=)
MXPA06002847A (es) Derivados de pirrol con actividad antibacterial.
JP2011503210A5 (https=)
JP2009534471A5 (https=)
BRPI0714225A2 (pt) compostos de efeito potencializador da atividade da etionamida e as respectivas aplicaÇÕes
JP2002535401A5 (https=)
JP2009518309A5 (https=)
PE20001583A1 (es) Derivados de la 1-arenosulfonil-2-arilo-pirrolidina y de la piperidina
JP2008513405A5 (https=)
NO20075022L (no) (7-(2-(4-(3-trifluormetylfenyl)-1,2,3,6-tetrahydropyrid-1-yl)etyl) isokinolinbesylatsalt, fremstilling og terapeutiske anvendelser derav